Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018.
Erin J Aiello BowlesCody RaminJacqueline B VoHeather Spencer FeigelsonJennifer C GanderLene H S VeigaClara BodelonRochelle E CurtisCarolyn BrandtAmy Berrington de GonzalezGretchen L GierachPublished in: Breast cancer research and treatment (2024)
One-third of women diagnosed with DCIS initiated endocrine therapy, and use decreased over time. Understanding why women eligible for endocrine therapy do not initiate is important to maximizing disease-free survival following DCIS diagnosis.